{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:33:11Z","timestamp":1787023991341,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3-4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.2119\/molmed.2010.00130","type":"journal-article","created":{"date-parts":[[2011,3,24]],"date-time":"2011-03-24T13:16:28Z","timestamp":1300972588000},"page":"241-247","source":"Crossref","is-referenced-by-count":18,"title":["CYP1A2*1F and GSTM1 Alleles Are Associated with Susceptibility to Porphyria Cutanea Tarda"],"prefix":"10.1186","volume":"17","author":[{"given":"Jeffrey K.","family":"Wickliffe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif Z.","family":"Abdel-Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csilla","family":"Kormos-Hallberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gagan","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Rondelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Grady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Desnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl E.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,10,15]]},"reference":[{"key":"17030241_CR1","first-page":"2991","volume":"2","author":"KE Anderson","year":"2001","unstructured":"Anderson KE, Sassa S, Bishop DF, Desnick RJ. (2001) Disorders of heme biosynthesis: X-linked sideroblastic anemias and the porphyrias. In: The Metabolic & Molecular Basis of Inherited Disease. 8th ed. Vol. 2. Scriver CR, Beaudet AL, Sly WS, Valle D (eds.) McGraw-Hill, New York, pp. 2991\u20133062.","journal-title":"The Metabolic & Molecular Basis of Inherited Disease"},{"key":"17030241_CR2","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.cgh.2009.11.017","volume":"8","author":"S Jalil","year":"2010","unstructured":"Jalil S, Grady JJ, Lee C, Anderson KE. (2010) Associations Among Behavior-Related Susceptibility Factors in Porphyria Cutanea Tarda. Clin. Gastroenterol. Hepatol. 2010 8:297\u2013302.","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"17030241_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/MD.0b013e3181d50928","volume":"89","author":"C Munoz-Santos","year":"2010","unstructured":"Munoz-Santos C, et al. (2010) Familial and sporadic porphyria cutanea tarda: clinical and biochemical features and risk factors in 152 patients. Medicine (Baltimore). 89:69\u201374.","journal-title":"Medicine (Baltimore)"},{"key":"17030241_CR4","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1001\/archderm.1964.01590300021006","volume":"89","author":"J Bleiberg","year":"1964","unstructured":"Bleiberg J, Wallen M, Brodkin R, Applebaum I. (1964) Industrially acquired porphyria. Arch. Dermatol. 89:793\u20137.","journal-title":"Arch. Dermatol."},{"key":"17030241_CR5","first-page":"88","volume":"183","author":"C Can","year":"1963","unstructured":"Can C, Nigogosyan G. (1963) Acquired toxic porphyria cutanea tarda due to hexachlorobenzene. Report of 348 cases caused by this fungicide. JAMA. 183:88\u201391.","journal-title":"JAMA"},{"issue":"Suppl1","key":"17030241_CR6","first-page":"37","volume":"105","author":"WE Daniell","year":"1997","unstructured":"Daniell WE, et al. (1997) Environmental chemical exposures and disturbances of heme synthesis. Environmental Health Perspectives 105 Suppl 1:37\u201353.","journal-title":"Environmental Health Perspectives"},{"key":"17030241_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/B978-0-08-092388-8.50010-8","volume-title":"Porphyrin Handbook, Part II","author":"GH Elder","year":"2003","unstructured":"Elder GH. (2003) Porphyria cutanea tarda and related disorders. In: Kadish KM, Smith K, Guilard R (eds.) Porphyrin Handbook, Part II. Academic Press, San Diego, pp. 67\u201392. Chapter 88."},{"key":"17030241_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0140-6736(85)90287-9","volume":"2","author":"GH Elder","year":"1985","unstructured":"Elder GH, Urquhart AJ, de Salamanca RE, Munoz JJ, Bonkovsky HL. (1985) Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda. Lancet. 2:229\u201333.","journal-title":"Lancet"},{"key":"17030241_CR9","doi-asserted-by":"publisher","first-page":"5079","DOI":"10.1073\/pnas.0700547104","volume":"104","author":"JD Phillips","year":"2007","unstructured":"Phillips JD, Bergonia HA, Reilly CA, Franklin MR, Kushner JP. (2007) A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda. Proc. Natl. Acad. Sci. U. S. A. 104:5079\u201384.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"17030241_CR10","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0006-2952(99)00088-X","volume":"58","author":"N Gorman","year":"1999","unstructured":"Gorman N, et al. (1999) Role of small differences in CYP1A2 in the development of uroporphyria produced by iron and 5-aminolevulinate in C57BL\/6 and SWR strains of mice. Biochem. Pharmacol. 58:375\u201382.","journal-title":"Biochem. Pharmacol."},{"key":"17030241_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1042\/bj3300149","volume":"330","author":"PR Sinclair","year":"1998","unstructured":"Sinclair PR, et al. (1998) Uroporphyria produced in mice by iron and 5-aminolaevulinic acid does not occur in Cyp1a2(\u2013\/\u2013) null mutant mice. Biochem. J. 330:149\u201353.","journal-title":"Biochem. J."},{"key":"17030241_CR12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1006\/taap.1999.8832","volume":"162","author":"PR Sinclair","year":"2000","unstructured":"Sinclair PR, et al. (2000) CYP1A2 is essential in murine uroporphyria caused by hexachloroben-zene and iron. Toxicol. Appl. Pharmacol. 162:60\u20137.","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"17030241_CR13","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0006-2952(02)01550-2","volume":"65","author":"RC Nichols","year":"2003","unstructured":"Nichols RC, et al. (2003) Uroporphyrin accumulation in hepatoma cells expressing human or mouse CYP1A2: relation to the role of CYP1A2 in human porphyria cutanea tarda. Biochem. Pharmacol. 65:545\u201350.","journal-title":"Biochem. Pharmacol."},{"key":"17030241_CR14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.toxlet.2004.12.005","volume":"156","author":"F Castorena-Torres","year":"2005","unstructured":"Castorena-Torres F, et al. (2005) CYP1A2 phenotype and genotype in a population from the carboniferous region of Coahuila, Mexico. Toxicol. Lett. 156:331\u20139.","journal-title":"Toxicol. Lett."},{"key":"17030241_CR15","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1046\/j.1365-2125.2002.01686.x","volume":"54","author":"XM Han","year":"2002","unstructured":"Han XM, et al. (2002) Inducibility of CYP1A2 by omeprazole in vivo related to the genetic polymorphism of CYP1A2. Br. J. Clin. Pharmacol. 54:540\u20133.","journal-title":"Br. J. Clin. Pharmacol."},{"key":"17030241_CR16","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1046\/j.1365-2125.1999.00898.x","volume":"47","author":"C Sachse","year":"1999","unstructured":"Sachse C, Brockmoller J, Bauer S, Roots I. (1999) Functional significance of a C\u2014>A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br. J. Clin. Pharmacol. 47:445\u20139.","journal-title":"Br. J. Clin. Pharmacol."},{"key":"17030241_CR17","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1007\/s004390000415","volume":"107","author":"L Christiansen","year":"2000","unstructured":"Christiansen L, et al. (2000) Association between CYP1A2 polymorphism and susceptibility to porphyria cutanea tarda. Hum. Genet. 107:612\u20134.","journal-title":"Hum. Genet."},{"key":"17030241_CR18","doi-asserted-by":"publisher","first-page":"e326","DOI":"10.1111\/j.1600-0625.2009.01040.x","volume":"19","author":"A Fontanellas","year":"2010","unstructured":"Fontanellas A, et al. (2010) Smoking but not homozygosity for CYP1A2 g-163A allelic variant leads to earlier disease onset in patients with sporadic porphyria cutanea tarda. Exp. Dermatol. 19:e326\u20138.","journal-title":"Exp. Dermatol."},{"key":"17030241_CR19","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1080\/00015550410025219","volume":"84","author":"O Dereure","year":"2004","unstructured":"Dereure O, et al. (2004) No significant association between CYP1A2 polymorphism and porphyria cutanea tarda. Acta. Derm. Venereol. 84:254\u20135.","journal-title":"Acta. Derm. Venereol."},{"key":"17030241_CR20","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/carcin\/21.4.669","volume":"21","author":"AK Alexandrie","year":"2000","unstructured":"Alexandrie AK, et al. (2000) CYP1A1 and GSTM1 polymorphisms affect urinary 1-hydroxypyrene levels after PAH exposure. Carcinogenesis. 21:669\u201376.","journal-title":"Carcinogenesis"},{"key":"17030241_CR21","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1093\/carcin\/23.12.1969","volume":"23","author":"K Alexandrov","year":"2002","unstructured":"Alexandrov K, et al. (2002) CYP1A1 and GSTM1 genotypes affect benzo[a]pyrene DNA adducts in smokers\u2019 lung: comparison with aromatic\/hydrophobic adduct formation. Carcinogenesis. 23:1969\u201377.","journal-title":"Carcinogenesis"},{"key":"17030241_CR22","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1158\/1055-9965.EPI-06-0291","volume":"15","author":"Y Chen","year":"2006","unstructured":"Chen Y, et al. (2006) Association of polymorphisms in AhR, CYP1A1, GSTM1, and GSTT1 genes with levels of DNA damage in peripheral blood lymphocytes among coke-oven workers. Cancer Epidemiol. Biomarkers Prev. 15:1703\u20137.","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"17030241_CR23","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/00008571-200008000-00005","volume":"10","author":"D Schwarz","year":"2000","unstructured":"Schwarz D, et al. (2000) Allelic variants of human cytochrome P450 1A1 (CYP1A1): effect of T461N and I462V substitutions on steroid hydroxylase specificity. Pharmacogenetics. 10:519\u201330.","journal-title":"Pharmacogenetics"},{"key":"17030241_CR24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.mrfmmm.2009.07.006","volume":"670","author":"PP Shah","year":"2009","unstructured":"Shah PP, Saurabh K, Pant MC, Mathur N, Parmar D. (2009) Evidence for increased cytochrome P450 1A1 expression in blood lymphocytes of lung cancer patients. Mutat. Res. 670:74\u20138.","journal-title":"Mutat. Res."},{"key":"17030241_CR25","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/j.0906-6705.2003.00095.x","volume":"12","author":"K Gardlo","year":"2003","unstructured":"Gardlo K, et al. (2003) Cytochrome p450A1 polymorphisms in a Caucasian population with porphyria cutanea tarda. Exp. Dermatol. 12:843\u20138.","journal-title":"Exp. Dermatol."},{"key":"17030241_CR26","doi-asserted-by":"publisher","first-page":"7293","DOI":"10.1073\/pnas.85.19.7293","volume":"85","author":"J Seidegard","year":"1988","unstructured":"Seidegard J, Vorachek WR, Pero RW, Pearson WR. (1988) Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc. Natl. Acad. Sci. U. S. A. 85:7293\u20137.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"17030241_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.mrfmmm.2007.02.022","volume":"620","author":"B Binkova","year":"2007","unstructured":"Binkova B, et al. (2007) PAH-DNA adducts in environmentally exposed population in relation to metabolic and DNA repair gene polymorphisms. Mutat. Res. 620:49\u201361.","journal-title":"Mutat. Res."},{"key":"17030241_CR28","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1124\/mol.64.3.659","volume":"64","author":"E Aklillu","year":"2003","unstructured":"Aklillu E, et al. (2003) Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1. Mol. Pharmacol. 64:659\u201369.","journal-title":"Mol. Pharmacol."},{"key":"17030241_CR29","first-page":"4965","volume":"56","author":"I Cascorbi","year":"1996","unstructured":"Cascorbi I, Brockmoller J, Roots I. (1996) A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res. 56:4965\u20139.","journal-title":"Cancer Res."},{"key":"17030241_CR30","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/j.1349-7006.1999.tb00832.x","volume":"90","author":"M Chida","year":"1999","unstructured":"Chida M, et al. (1999) Detection of three genetic polymorphisms in the 5\u2032-flanking region and intron 1 of human CYP1A2 in the Japanese population. Jpn. J. Cancer Res. 90:899\u2013902.","journal-title":"Jpn. J. Cancer Res."},{"key":"17030241_CR31","doi-asserted-by":"publisher","first-page":"5901","DOI":"10.1093\/nar\/15.14.5901","volume":"15","author":"NK Spurr","year":"1987","unstructured":"Spurr NK, Gough AC, Stevenson K, Wolf CR. (1987) Msp-1 polymorphism detected with a cDNA probe for the P-450 I family on chromosome 15. Nucleic Acids Res. 15:5901.","journal-title":"Nucleic Acids Res."},{"key":"17030241_CR32","doi-asserted-by":"publisher","first-page":"7194","DOI":"10.1093\/nar\/18.23.7194","volume":"18","author":"J Watanabe","year":"1990","unstructured":"Watanabe J, et al. (1990) PstI and RsaI RFLPs in complete linkage disequilibrium at the CYP2E gene. Nucleic Acids Res. 18:7194.","journal-title":"Nucleic Acids Res."},{"key":"17030241_CR33","first-page":"3926","volume":"56","author":"ZY Zhang","year":"1996","unstructured":"Zhang ZY, Fasco MJ, Huang L, Guengerich FP, Kaminsky LS. (1996) Characterization of purified human recombinant cytochrome P4501A1-Ile462 and -Val462: assessment of a role for the rare allele in carcinogenesis. Cancer Res. 56:3926\u201333.","journal-title":"Cancer Res."},{"key":"17030241_CR34","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1023\/A:1013746828074","volume":"47","author":"NG Egger","year":"2002","unstructured":"Egger NG, et al. (2002) Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency. Dig. Dis. Sci. 47:419\u201326.","journal-title":"Dig. Dis. Sci."},{"key":"17030241_CR35","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1399-0004.2009.01153.x","volume":"75","author":"C Badenas","year":"2009","unstructured":"Badenas C, et al. (2009) Identification and characterization of novel uroporphyrinogen decarboxylase gene mutations in a large series of porphyria cutanea tarda patients and relatives. Clin. Genet. 75:346\u201353.","journal-title":"Clin. Genet."},{"key":"17030241_CR36","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0304-3835(96)04832-X","volume":"107","author":"SZ Abdel-Rahman","year":"1996","unstructured":"Abdel-Rahman SZ, el-Zein RA, Anwar WA, Au WW. (1996) A multiplex PCR procedure for polymorphic analysis of GSTM1 and GSTT1 genes in population studies. Cancer Lett. 107:229\u201333.","journal-title":"Cancer Lett."},{"key":"17030241_CR37","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1093\/bioinformatics\/btg276","volume":"19","author":"K Ding","year":"2003","unstructured":"Ding K, Zhou K, He F, Shen Y. (2003) LDA\u2014a java-based linkage disequilibrium analyzer. Bioinformatics. 19:2147\u20138.","journal-title":"Bioinformatics"},{"key":"17030241_CR38","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1006\/taap.1997.8282","volume":"147","author":"MR Franklin","year":"1997","unstructured":"Franklin MR, Phillips JD, Kushner JP. (1997) Cytochrome P450 induction, uroporphyrinogen decarboxylase depression, porphyrin accumulation and excretion, and gender influence in a 3-week rat model of porphyria cutanea tarda. Toxicol. Appl. Pharmacol. 147:289\u201399.","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"17030241_CR39","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nature02168","volume":"426","author":"International HapMap Consortium","year":"2003","unstructured":"International HapMap Consortium. (2003) The International HapMap Project. Nature. 426:789\u201396.","journal-title":"Nature"},{"key":"17030241_CR40","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0300-483X(00)00238-9","volume":"150","author":"S Ahmad","year":"2000","unstructured":"Ahmad S, Agrawal R, Agrawal DK, Rao GS. (2000) Bioreactivity of glutathionyl hydroquinone with implications to benzene toxicity. Toxicology. 150:31\u20139.","journal-title":"Toxicology"},{"key":"17030241_CR41","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0009-2797(88)90021-X","volume":"68","author":"A Brunmark","year":"1988","unstructured":"Brunmark A, Cadenas E. (1988) Reductive addition of glutathione to p-benzoquinone, 2-hydroxy-p-benzoquinone, and p-benzoquinone epoxides. Effect of the hydroxy- and glutathionyl substituents on p-benzohydroquinone autoxidation. Chem. Biol. Interact. 68:273\u201398.","journal-title":"Chem. Biol. Interact."},{"key":"17030241_CR42","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0891-5849(88)90076-7","volume":"5","author":"A Brunmark","year":"1988","unstructured":"Brunmark A, Cadenas E, Segura-Aguilar J, Lind C, Ernster L. (1988) DT-diaphorase-catalyzed two-electron reduction of various p-benzoquinone-and 1,4-naphthoquinone epoxides. Free Radic. Biol. Med. 5:133\u201343.","journal-title":"Free Radic. Biol. Med."},{"key":"17030241_CR43","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3109\/00498259309059415","volume":"23","author":"W Dekant","year":"1993","unstructured":"Dekant W, Vamvakas S. (1993) Glutathione-dependent bioactivation of xenobiotics. Xenobiotica. 23:873\u201387.","journal-title":"Xenobiotica"},{"key":"17030241_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0041-008X(90)90100-9","volume":"106","author":"TJ Monks","year":"1990","unstructured":"Monks TJ, et al. (1990) Glutathione conjugate mediated toxicities. Toxicol. Appl. Pharmacol. 106:1\u201319.","journal-title":"Toxicol. Appl. Pharmacol."}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.crossref.org\/molmed.2010.00130","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2010.00130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,6]],"date-time":"2019-04-06T00:44:48Z","timestamp":1554511488000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.2119\/molmed.2010.00130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,15]]},"references-count":44,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["17030241"],"URL":"https:\/\/doi.org\/10.2119\/molmed.2010.00130","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,15]]}}}